The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Influenza Vaccination-Global Market Insights and Sales Trends 2025
Synopsis
Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
The global Influenza Vaccination market size is expected to reach US$ 4872.9 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Influenza Vaccination in various end use industries. The expanding demands from the Hospitals and Research Organizations, are propelling Influenza Vaccination market. Egg Based, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cell Culture segment is estimated at % CAGR for the next seven-year period.
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Influenza Vaccination, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Influenza Vaccination market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Influenza Vaccination market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Influenza Vaccination sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Influenza Vaccination covered in this report include Abbott (U.S.), AstraZeneca (Europe), BioCryst Pharmaceuticals (U.S.), Novartis (Europe), DAIICHI SANKYO COMPANY (Asia Pacific), GlaxoSmithKline (Europe), Hualan Biological Engineering (Asia Pacific), Mitsubishi Tanabe Pharma (Asia Pacific) and F. Hoffmann-La Roche (Europe), etc.
The global Influenza Vaccination market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals (U.S.)
Novartis (Europe)
DAIICHI SANKYO COMPANY (Asia Pacific)
GlaxoSmithKline (Europe)
Hualan Biological Engineering (Asia Pacific)
Mitsubishi Tanabe Pharma (Asia Pacific)
F. Hoffmann-La Roche (Europe)
Sanofi (Europe)
Global Influenza Vaccination market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Influenza Vaccination market, Segment by Type:
Egg Based
Cell Culture
Recombinant
Global Influenza Vaccination market, by Application
Hospitals
Research Organizations
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Influenza Vaccination companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
The global Influenza Vaccination market size is expected to reach US$ 4872.9 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Influenza Vaccination in various end use industries. The expanding demands from the Hospitals and Research Organizations, are propelling Influenza Vaccination market. Egg Based, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cell Culture segment is estimated at % CAGR for the next seven-year period.
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Influenza Vaccination, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Influenza Vaccination market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Influenza Vaccination market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Influenza Vaccination sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Influenza Vaccination covered in this report include Abbott (U.S.), AstraZeneca (Europe), BioCryst Pharmaceuticals (U.S.), Novartis (Europe), DAIICHI SANKYO COMPANY (Asia Pacific), GlaxoSmithKline (Europe), Hualan Biological Engineering (Asia Pacific), Mitsubishi Tanabe Pharma (Asia Pacific) and F. Hoffmann-La Roche (Europe), etc.
The global Influenza Vaccination market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals (U.S.)
Novartis (Europe)
DAIICHI SANKYO COMPANY (Asia Pacific)
GlaxoSmithKline (Europe)
Hualan Biological Engineering (Asia Pacific)
Mitsubishi Tanabe Pharma (Asia Pacific)
F. Hoffmann-La Roche (Europe)
Sanofi (Europe)
Global Influenza Vaccination market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Influenza Vaccination market, Segment by Type:
Egg Based
Cell Culture
Recombinant
Global Influenza Vaccination market, by Application
Hospitals
Research Organizations
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Influenza Vaccination companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Influenza Vaccination
1.1 Influenza Vaccination Market Overview
1.1.1 Influenza Vaccination Product Scope
1.1.2 Influenza Vaccination Market Status and Outlook
1.2 Global Influenza Vaccination Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Influenza Vaccination Market Size by Region (2018-2029)
1.4 Global Influenza Vaccination Historic Market Size by Region (2018-2023)
1.5 Global Influenza Vaccination Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Influenza Vaccination Market Size (2018-2029)
1.6.1 North America Influenza Vaccination Market Size (2018-2029)
1.6.2 Europe Influenza Vaccination Market Size (2018-2029)
1.6.3 Asia-Pacific Influenza Vaccination Market Size (2018-2029)
1.6.4 Latin America Influenza Vaccination Market Size (2018-2029)
1.6.5 Middle East & Africa Influenza Vaccination Market Size (2018-2029)
2 Influenza Vaccination Market by Type
2.1 Introduction
2.1.1 Egg Based
2.1.2 Cell Culture
2.1.3 Recombinant
2.2 Global Influenza Vaccination Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Influenza Vaccination Historic Market Size by Type (2018-2023)
2.2.2 Global Influenza Vaccination Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Influenza Vaccination Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Influenza Vaccination Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Influenza Vaccination Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Influenza Vaccination Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Influenza Vaccination Revenue Breakdown by Type (2018-2029)
3 Influenza Vaccination Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Research Organizations
3.2 Global Influenza Vaccination Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Influenza Vaccination Historic Market Size by Application (2018-2023)
3.2.2 Global Influenza Vaccination Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Influenza Vaccination Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Influenza Vaccination Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Influenza Vaccination Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Influenza Vaccination Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Influenza Vaccination Revenue Breakdown by Application (2018-2029)
4 Influenza Vaccination Competition Analysis by Players
4.1 Global Influenza Vaccination Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Vaccination as of 2022)
4.3 Date of Key Players Enter into Influenza Vaccination Market
4.4 Global Top Players Influenza Vaccination Headquarters and Area Served
4.5 Key Players Influenza Vaccination Product Solution and Service
4.6 Competitive Status
4.6.1 Influenza Vaccination Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott (U.S.)
5.1.1 Abbott (U.S.) Profile
5.1.2 Abbott (U.S.) Main Business
5.1.3 Abbott (U.S.) Influenza Vaccination Products, Services and Solutions
5.1.4 Abbott (U.S.) Influenza Vaccination Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott (U.S.) Recent Developments
5.2 AstraZeneca (Europe)
5.2.1 AstraZeneca (Europe) Profile
5.2.2 AstraZeneca (Europe) Main Business
5.2.3 AstraZeneca (Europe) Influenza Vaccination Products, Services and Solutions
5.2.4 AstraZeneca (Europe) Influenza Vaccination Revenue (US$ Million) & (2018-2023)
5.2.5 AstraZeneca (Europe) Recent Developments
5.3 BioCryst Pharmaceuticals (U.S.)
5.3.1 BioCryst Pharmaceuticals (U.S.) Profile
5.3.2 BioCryst Pharmaceuticals (U.S.) Main Business
5.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Products, Services and Solutions
5.3.4 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis (Europe) Recent Developments
5.4 Novartis (Europe)
5.4.1 Novartis (Europe) Profile
5.4.2 Novartis (Europe) Main Business
5.4.3 Novartis (Europe) Influenza Vaccination Products, Services and Solutions
5.4.4 Novartis (Europe) Influenza Vaccination Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis (Europe) Recent Developments
5.5 DAIICHI SANKYO COMPANY (Asia Pacific)
5.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Profile
5.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Main Business
5.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Products, Services and Solutions
5.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Revenue (US$ Million) & (2018-2023)
5.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments
5.6 GlaxoSmithKline (Europe)
5.6.1 GlaxoSmithKline (Europe) Profile
5.6.2 GlaxoSmithKline (Europe) Main Business
5.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Products, Services and Solutions
5.6.4 GlaxoSmithKline (Europe) Influenza Vaccination Revenue (US$ Million) & (2018-2023)
5.6.5 GlaxoSmithKline (Europe) Recent Developments
5.7 Hualan Biological Engineering (Asia Pacific)
5.7.1 Hualan Biological Engineering (Asia Pacific) Profile
5.7.2 Hualan Biological Engineering (Asia Pacific) Main Business
5.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Products, Services and Solutions
5.7.4 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Revenue (US$ Million) & (2018-2023)
5.7.5 Hualan Biological Engineering (Asia Pacific) Recent Developments
5.8 Mitsubishi Tanabe Pharma (Asia Pacific)
5.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Profile
5.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Main Business
5.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Products, Services and Solutions
5.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Revenue (US$ Million) & (2018-2023)
5.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments
5.9 F. Hoffmann-La Roche (Europe)
5.9.1 F. Hoffmann-La Roche (Europe) Profile
5.9.2 F. Hoffmann-La Roche (Europe) Main Business
5.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Products, Services and Solutions
5.9.4 F. Hoffmann-La Roche (Europe) Influenza Vaccination Revenue (US$ Million) & (2018-2023)
5.9.5 F. Hoffmann-La Roche (Europe) Recent Developments
5.10 Sanofi (Europe)
5.10.1 Sanofi (Europe) Profile
5.10.2 Sanofi (Europe) Main Business
5.10.3 Sanofi (Europe) Influenza Vaccination Products, Services and Solutions
5.10.4 Sanofi (Europe) Influenza Vaccination Revenue (US$ Million) & (2018-2023)
5.10.5 Sanofi (Europe) Recent Developments
6 North America
6.1 North America Influenza Vaccination Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Influenza Vaccination Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Influenza Vaccination Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Influenza Vaccination Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Influenza Vaccination Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Influenza Vaccination Market Dynamics
11.1 Influenza Vaccination Industry Trends
11.2 Influenza Vaccination Market Drivers
11.3 Influenza Vaccination Market Challenges
11.4 Influenza Vaccination Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
